| Anderson WF
Structural genomics and drug discovery for infectious diseases. [Journal Article, Research Support, N.I.H., Extramural]
Infect Disord Drug Targets 2009 Nov; 9(5):507-17.
Abstract | Full Citation | Find Related Articles |
| Chen YW
Structural genomics. [Editorial, Introductory Journal Article]
Infect Disord Drug Targets 2009 Nov; 9(5):457-8.
Full Citation | Find Related Articles |
| Kalpakcioglu B, Senel K
The role of melatonin in rheumatic diseases. [Journal Article]
Infect Disord Drug Targets 2009 Aug; 9(4):453-6.
Abstract | Full Citation | Find Related Articles |
| Elswaifi SF, Palmieri JR, Hockey KS, et al.
Antioxidant nanoparticles for control of infectious disease. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Infect Disord Drug Targets 2009 Aug; 9(4):445-52.
Abstract | Full Citation | Find Related Articles |
| Ji LL, Gomez-Cabrera MC, Vina J
Role of free radicals and antioxidant signaling in skeletal muscle health and pathology. [Journal Article]
Infect Disord Drug Targets 2009 Aug; 9(4):428-44.
Abstract | Full Citation | Find Related Articles |
| Soory M
Redox status in periodontal and systemic inflammatory conditions including associated neoplasias: antioxidants as adjunctive therapy? [Journal Article]
Infect Disord Drug Targets 2009 Aug; 9(4):415-27.
Abstract | Full Citation | Find Related Articles |
| Soory M
Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. [Journal Article]
Infect Disord Drug Targets 2009 Aug; 9(4):400-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Tsoupras AB, Iatrou C, Frangia C, et al.
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. [Journal Article]
Infect Disord Drug Targets 2009 Aug; 9(4):390-9.
Abstract | Full Citation |
| Víctor VM, Espulgues JV, Hernández-Mijares A, et al.
Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. [Journal Article, Research Support, Non-U.S. Gov't]
Infect Disord Drug Targets 2009 Aug; 9(4):376-89.
Abstract | Full Citation | Find Related Articles |
| Soory M
Redox status in the pathophysiology of inflammation and therapeutic targets. [Editorial]
Infect Disord Drug Targets 2009 Aug; 9(4):375.
Full Citation | Find Related Articles |
  |
